-
公开(公告)号:US20170246198A1
公开(公告)日:2017-08-31
申请号:US15519846
申请日:2015-10-20
申请人: Bryon L. Simmons , Kevin R. Campos , Artis Klapars , Alistair J. Stewart , Benjamin A. Mayes , Peter E. Maligres , Alan Hyde , Steven Mark Silverman , Yong-Li Zhong , Adei M. Moussa , Kenneth Baker , Kara van Valkenburg , IDENIX PHARMACEUTICALS LLC
发明人: Bryon L. SIMMONS , Kevin R. CAMPOS , Artis KLAPARS , Alistair J. STEWART , Benjamin A. MAYES , Peter E. MALIGRES , Alan HYDE , Steven Mark SILVERMAN , Yong-Li ZHONG , Adel M. MOUSSA , Kenneth BAKER , Kara van VALKENBURG
IPC分类号: A61K31/7052 , C08K3/08 , C07H19/10
CPC分类号: A61K31/7052 , C07H1/00 , C07H19/10 , C08K3/08 , C08K2003/0812 , C08K2003/0856 , C08K2003/0893
摘要: The present invention is directed to a process for making Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).